It is very uncertain whether antibiotics plus probiotics changes withdrawals due to adverse events compared with placebo or no intervention (very low certainty).

1 finding from 1 review

Antibiotics for the induction and maintenance of remission in ulcerative colitis 2022 · Cochrane Headline outcomes only
RR 1 [0.07, 15.08]
2 studies · 98 participants
Very low

Medicine‐separated moxibustion combined with acupuncture vs wheat bran‐separated moxibustion combined with shallow acupuncture

Withdrawals due to adverse events · people with Crohn's disease

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 102 participants
Very low

Web‐based education vs standard book‐based education

Withdrawals due to adverse events · people with inflammatory bowel disease

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Relaxation vs WAIT LIST

Withdrawals due to adverse events · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Stellate ganglion block vs sulphasalazine

Withdrawals due to adverse events · UC patients

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in ulcerative colitis 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mesalamine vs placebo

Withdrawals due to adverse events · Patients with collagenous colitis

Mesalamine showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 5.92 [0.7, 49.9]
1 study · 62 participants
Low

Budesonide vs placebo

Withdrawals due to adverse events · Patients with collagenous colitis

It is very uncertain whether budesonide changes withdrawals due to adverse events compared with placebo (very low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 0.97 [0.43, 2.17]
5 studies · 290 participants
Very low

Boswellia serrata vs placebo

Withdrawals due to adverse events · Patients with collagenous colitis

Boswellia serrata extract showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 2.82 [0.12, 64.39]
1 study · 31 participants
Low

Budesonide vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Withdrawals due to adverse events · Patients with collagenous colitis

Budesonide showed no clear difference in withdrawals due to adverse events compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 0.09 [0.01, 1.65]
1 study · 55 participants
Low